Delivery Order SPE2DB20D1047-SPE2DB25FF39B

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,439.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with an ultimate completion date of December 5, 2024. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,943.11, is a Firm Fixed Price Delivery Order for the procurement of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,272.60 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,402.66 firm fixed-price delivery order is for the supply of 4567240666 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. There was no set-aside designation used for this contract. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a ceiling value of $2,250.09. The contract is a Firm Fixed Price Delivery Order with a period of performance through June 30, 2025. There is no set-aside designation, indicating this was an open competition....
This federal contract award is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,455.09 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is set to be completed by November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award, identified as SPE2DB22D1202|SPE2DB25FURA0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567085004 ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a ceiling value of $9,686.72. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 30, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.47 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 UD 24S, a pharmaceutical product. The contract has a period of performance through March 12, 2024 and was awarded on March 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $13,690.26 for the procurement of ATOVAQUONE-PROGUANIL 250-100 100S, which are medical commodities used in healthcare. The contract has an ultimate completion date of April 3, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,586.15, is a Firm Fixed Price Delivery Order for the supply of 4567677579 ! ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF39B
    Delivery Order

This federal contract award, with the ID SPE2DB20D1047|SPE2DB25FF39B, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,229.02, is a Firm Fixed Price Delivery Order for the provision of ATOVAQUONE-PROGUANIL 250-100 24S, a pharmaceutical product.

The contract award is not designated as a set-aside and has an ultimate completion date of January 27, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:24 AM